Meeting Report
Updates in Cholangiocarcinoma
Kristen O’Hagan, MSN, RN, ANP-BC, AOCNP®
From Memorial Sloan Kettering Cancer Center, New York, New York
Presenter’s disclosure of conflicts of interest is found at the end of this article.
J Adv Pract Oncol 2022;13(3):320–323 |
https://doi.org/10.6004/jadpro.2022.13.3.28 |
© 2022 Harborside™
ABSTRACT
Cholangiocarcinoma is a spectrum of invasive adenocarcinomas that arise in the intrahepatic, perihilar, or distal biliary tree, and is classified by location. During JADPRO Live Virtual 2021, Kristen O’Hagan, MSN, RN, ANP-BC, AOCNP®, discussed this complex disease, current treatment strategies, and the role of targeted therapy and how it’s changing the treatment landscape for cholangiocarcinoma.
For access to the full length article, please
sign in.
